OCT 12, 2020 2:30 PM PDT

Researchers Solve Key Problem for Cancer Immunotherapy

WRITTEN BY: Annie Lennon

Cancer immunotherapies are becoming increasingly promising as a standard-of-care treatment. However, despite their promise, they still don't work for everyone. Now, researchers may have both found why this is- and a way to resolve the issue. 

Checkpoint inhibitors are a type of immunotherapy that work by targeting specific proteins, such as PD-L1, that exist on tumor cells and signal the body's immune system not to attack them. Although effective in some cases, patients can develop resistance to these therapies if their cancer has spread beyond its initial location to form additional tumors on their liver. 

For their study, the researchers simulated this process by implanting mice with cancer cells under the skin and then either in their liver or lungs. In doing so, they found that, unlike in the lungs, cancer cells in the liver were 'uniquely suppressive'. There, it appeared they were able to take advantage of the liver's signaling mechanisms to retrain the immune system to ignore cancer cells both there and elsewhere in the body. 

As such, the researchers found that after anti-PD-1 treatment, mice with secondary cancers in their livers had significantly lower survival rates than those with cancer in their lungs. 

To find out why this was the case, the researchers later conducted single-cell analyses and found that liver tumors were able to change which genes were expressed in regulatory T cells (immune cells that suppress the immune response also known as 'Tregs') and from there, multiple other immune system cells too. Rather than a difference in the quantity of T cells, the researchers found that cancer in the liver led to a difference in their quality. 

As such, the researchers tested two drugs to see if they could override this effect. While both were effective in restoring the efficacy of anti-PD-1 therapy, they found that the second drug, an anti-CLTA-4 compound that targets regulatory T cells directly and depletes their numbers, was more effective. 

"We've never had this kind of precision in immunotherapy in the past," says James Lee, lead author of the research. "What if, right from the start, you could use a drug that depletes Tregs as a complement to immunotherapy in patients with liver metastasis?"

 

Sources: EurekAlertUCSF

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
AUG 07, 2020
Chemistry & Physics
Excipients: "Inactive" Drug Components Could Be Functioning Beyond Their Scopes
AUG 07, 2020
Excipients: "Inactive" Drug Components Could Be Functioning Beyond Their Scopes
Excipients are chemical additives to medications. They are incorporated into all kinds of pharmaceuticals to fulfil ...
AUG 18, 2020
Drug Discovery & Development
Psychedelic Medicine Reduces Inflammation from Asthma
AUG 18, 2020
Psychedelic Medicine Reduces Inflammation from Asthma
Aside from mental health applications, psychedelics are also known for their antiinflammatory effects. And now, a compan ...
AUG 22, 2020
Drug Discovery & Development
New Class of Antibiotics Could Treat UTIs
AUG 22, 2020
New Class of Antibiotics Could Treat UTIs
At 11 million cases annually, urinary tract infections (UTIs) are the most common outpatient infections in the U.S., Sci ...
SEP 07, 2020
Microbiology
How THC Can Help Relieve a Respiratory Disorder
SEP 07, 2020
How THC Can Help Relieve a Respiratory Disorder
Acute respiratory distress syndrome (ARDS) occurs when fluid builds up in the sacs in the lungs that hold air, and the l ...
SEP 13, 2020
Drug Discovery & Development
Scientists Find Way to Reduce Inflammation from Vaccines
SEP 13, 2020
Scientists Find Way to Reduce Inflammation from Vaccines
Researchers from the University of Chicago have found a new way to reduce vaccine-related inflammation from adjuvants, a ...
OCT 12, 2020
Cannabis Sciences
Can Cannabis Relieve Symptoms of Down Syndrome?
OCT 12, 2020
Can Cannabis Relieve Symptoms of Down Syndrome?
Increasing anecdotal and academic evidence has been emerging in recent years about the plethora of health benefits behin ...
Loading Comments...